(Date:12/14/2009)... 14 Dyadic International, Inc. (Pink Sheets: ... its collaboration with The Scripps Research Institute ("Scripps") ... re-annotate the genome of Dyadic,s patented and proprietary ... continuation of the successful relationship between the two ... engaged Scripps to annotate the C1 genome for ...
(Date:12/14/2009)... Boston Scientific Corporation (NYSE: BSX ... of $2 billion aggregate principal amount of its senior ... public offering consists of $850 million of 4.50 percent ... notes due January 2020 and $300 million of 7.375 ... to use the net proceeds for general corporate purposes, ...
(Date:12/14/2009)... Mass., Dec. 14 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that, owing ... atrial fibrillation drug market will increase more than ... billion in 2018 in the United States, France, ... ,, The new Pharmacor report entitled Atrial ...
(Date:12/11/2009)... ROCKVILLE, Md., Dec. 11 EntreMed, Inc. ... of $1.7 million in royalty revenue from sales ... estimated royalty revenue of $3.3 million. In ... quarter and projected revenue for fiscal 2009. ... the third quarter will be reflected in the ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2EntreMed Reports Receipt of Third Quarter Royalty Payment 2... 7 Physicians and patients of,community-based ... benefit from,a new partnership between Physicians ... providing resources to help local physicians ... patient care., (Logo: http://www.newscom.com/cgi-bin/prnh/20070904/NETU093LOGO ...
... Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) (,Oncolytics,) ... Dr. Richard Vile of the Mayo Clinic ... results of its work testing the antitumor ... and cyclophosphamide in,vivo. The paper, entitled "Cyclophosphamide ...
... Calif., Jan. 7 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products ... Extended Terminal promulgated the test results on,Kiwa,s ... Peng Jia Bao", both of,which passed fertilizer ... the previous Temporary Amino Acid Leaf Fertilizer,Registration ...
Other Biology Technology:Physicians Practice, Loma Linda Partner to Improve Patient Care in Southern California 2Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment 2Kiwa Fertilizers Pass Independent Tests 2Kiwa Fertilizers Pass Independent Tests 3Mouse monoclonal [002-49] to C1s ( Abpromise for all tested applications). entrezGeneID: 716 SwissProtID: P09871...
Rabbit polyclonal to Oct2, prediluted ( Abpromise for all tested applications). entrezGeneID: 5452 SwissProtID: P09086...
Selenoprotein P Purified Anti-Mouse clone 35, Isotype Mouse IgG 2b , 50 µg Consult technical datasheet for details....
Oct 2 Immunogen: Full length human protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products:Biology NavigationMedical Navigation